BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

PSEN1 inhibition could treat T cell ALL

Claire Quang
June 11, 2019 9:53 PM UTC

INDICATION: Acute lymphoblastic leukemia (ALL)...

BCIQ Company Profiles

Flanders Institute for Biotechnology (Vib)

Ku Leuven

BCIQ Target Profiles

Presenilin 1 (PSEN1) (PS1)

BCIQ Company Profiles

Flanders Institute for Biotechnology (Vib)

Ku Leuven

BCIQ Target Profiles

Presenilin 1 (PSEN1) (PS1)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS